Thus, an increase in the percentage of circulating intermediate and NCM subsets can be regarded as an appropriate prognostic marker in patients with coronary artery atherosclerosis, while Lp(a) may have no prognostic value. The gene discussed is LPA; the disease is coronary atherosclerosis.